Description
Product details
Pacemolol Injection Generic Name: Esmolol Hydrochloride Dosage Form: Injection Pacemolol Injection contains Esmolol Hydrochloride, an ultra-short-acting, selective beta-1 adrenergic receptor blocker used for rapid and temporary control of heart rate in selected acute cardiovascular situations. Esmolol primarily blocks beta-1 receptors in the heart, resulting in decreased heart rate, reduced myocardial contractility, and reduced cardiac workload. Its very short duration of action allows the clinical effect to be rapidly adjusted by changing or stopping the intravenous infusion. Depending on approved labeling, esmolol may be used for short-term management of supraventricular tachycardia and rapid ventricular rate in certain atrial arrhythmias, as well as selected cases of perioperative tachycardia or hypertension. Dosage & Administration Pacemolol Injection is intended for intravenous administration in an appropriately monitored healthcare setting. Dosage and infusion rate depend on: Heart rate Blood pressure Type of arrhythmia Cardiovascular status Clinical response Concurrent cardiovascular medicines Because esmolol acts rapidly and has a short duration of action, the infusion can be titrated according to the patient's response. Precautions Continuously or frequently monitor heart rate and blood pressure as clinically appropriate. Use cautiously in patients with heart failure or impaired cardiac function. Inform the physician about existing heart block or significant bradycardia. Additional caution is required when used with other medicines that slow heart rate or AV conduction. Beta-blockers can mask some symptoms of hypoglycemia. Although beta-1 selective, esmolol may still affect the airways at higher exposures and requires caution in bronchospastic disease. Monitor the IV administration site. Pregnancy and breastfeeding require appropriate medical assessment. Side Effects Possible adverse effects include: Low blood pressure Slow heart rate Dizziness Nausea Weakness Injection-site reactions Important adverse effects can include: Severe hypotension Significant bradycardia Heart block Worsening heart failure Bronchospasm in susceptible patients Warning Pacemolol Injection should be administered only under qualified medical supervision with appropriate cardiovascular monitoring. Hypotension and bradycardia are important dose-related effects of intravenous esmolol. If clinically significant effects occur, reducing or discontinuing the infusion generally allows relatively rapid recovery because of esmolol's short elimination half-life. FAQ 1. What does Pacemolol Injection contain? It contains Esmolol Hydrochloride, an ultra-short-acting beta-blocker. 2. What is Esmolol Injection used for? It may be used for rapid short-term control of heart rate in certain supraventricular tachyarrhythmias and for selected perioperative cardiovascular indications. 3. How does Esmolol work? It primarily blocks beta-1 receptors in the heart, reducing heart rate and cardiac workload. 4. Why is Esmolol called an ultra-short-acting beta-blocker? Esmolol is rapidly metabolized, giving it a very short elimination half-life and short duration of action compared with many other beta-blockers. 5. How is Pacemolol administered? Esmolol is administered intravenously, with dosing adjusted according to cardiovascular response and the approved protocol. 6. Can Pacemolol lower blood pressure? Yes. Hypotension is an important adverse effect of esmolol and requires appropriate monitoring. 7. Can Esmolol cause a slow heartbeat? Yes. Bradycardia can occur, particularly with higher exposure or when combined with other heart-rate-lowering medicines. 8. Does Pacemolol require cardiac monitoring? Yes. Because esmolol can rapidly affect heart rate, blood pressure, and cardiac conduction, appropriate cardiovascular monitoring is required during administration.
